Skip to main content

Sex affects myocardial blood flow and fatty acid substrate metabolism in humans with nonischemic heart failure.

Citation
Kadkhodayan, A., et al. “Sex Affects Myocardial Blood Flow And Fatty Acid Substrate Metabolism In Humans With Nonischemic Heart Failure.”. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology, pp. 1226-1235.
Center Washington University in St Louis
Author Ana Kadkhodayan, Huie Lin, Andrew R Coggan, Zulfia Kisrieva-Ware, Kenneth B Schechtman, Eric Novak, Susan M Joseph, Victor G Davila-Roman, Robert J Gropler, Carmen Dence, Linda R Peterson
Keywords Sex, fatty acid imaging, Heart failure, metabolism: PET, myocardial perfusion imaging: PET
Abstract

BACKGROUND: In animal models of heart failure (HF), myocardial metabolism shifts from high-energy fatty acid (FA) metabolism toward glucose. However, FA (vs glucose) metabolism generates more ATP/mole; thus, FA metabolism may be especially advantageous in HF. Sex modulates myocardial blood flow (MBF) and substrate metabolism in normal humans. Whether sex affects MBF and metabolism in patients with HF is unknown.

METHODS AND RESULTS: We studied 19 well-matched men and women with nonischemic HF (EF ≤ 35%). MBF and myocardial substrate metabolism were quantified using positron emission tomography. Women had higher MBF (mL/g/minute), FA uptake (mL/g/minute), and FA utilization (nmol/g/minute) (P < 0.005, P < 0.005, P < 0.05, respectively) and trended toward having higher FA oxidation than men (P = 0.09). These findings were independent of age, obesity, and insulin resistance. There were no sex-related differences in fasting myocardial glucose uptake or metabolism. Higher MBF was related to improved event-free survival (HR 0.31, P = 0.02).

CONCLUSIONS: In nonischemic HF, women have higher MBF and FA uptake and metabolism than men, irrespective of age, obesity, or insulin resistance. Moreover, higher MBF portends a better prognosis. These sex-related differences should be taken into account in the development and targeting of novel agents aimed at modulating MBF and metabolism in HF.

Year of Publication
2017
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Volume
24
Issue
4
Number of Pages
1226-1235
Date Published
12/2017
ISSN Number
1532-6551
DOI
10.1007/s12350-016-0467-6
Alternate Journal
J Nucl Cardiol
PMID
27048307
PMCID
PMC5517366
Download citation